GSK3B and Alzheimer disease: The indirect pathway of Aβ, mediated through norepinephrine α2A adrenergic receptor (α2AAR) signaling, surpasses direct GSK3β activation in terms of potency,127 underscoring its crucial role in the pathogenesis of AD.